US Pharma MarketingUniQure readout tests durability of benefits, an AI effort to manage heart failure, and more biotech news from The Readout Congress Physicians states Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Billing Log Out Reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account Home Newsletter The Readout FDA expands Bayer lung cancer drug approval UniQure readout tests durability of benefits, an AI effort…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Today, we look at how regulators are trying to keep pace with agentic medical AI, see the FDA launch a project to examine why pregnancy registries struggle with enrollment, and more.
Someone out there cure asthma, eh? It sucks.
Source: STAT News Pharma